查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1866938

體外循環系統市場按產品類型、組件、技術、應用和最終用戶分類－2025年至2032年全球預測

Extracorporeal Circulation System Market by Product Type, Component, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，體外循環系統市場規模將達到 27.8 億美元，複合年成長率為 8.36%。

關鍵市場統計數據
基準年 2024 14.6億美元
預計年份：2025年 15.8億美元
預測年份 2032 27.8億美元
複合年成長率 (%) 8.36%

一個不斷演進的臨床和技術要求框架，它定義了體外循環系統，並影響採購和實施決策。

現代體外循環系統領域在心臟外科手術和高階呼吸支援的交叉領域發揮核心作用，這得益於技術的不斷進步和臨床通訊協定的不斷發展。近年來，隨著醫院和專科醫療中心在複雜心臟心血管手術和嚴重呼吸衰竭治療方面的能力提升，心肺體外迴圈機和體外膜氧合（ECMO）平台都受到了越來越多的關注。本文概述了這個生態系統，重點介紹了臨床促進因素、組件層面的創新以及影響採購和實施決策的政策背景。

臨床醫生越來越需要整合安全功能、易於啟動和簡化工作流程的系統，以縮短手術時間並提高患者吞吐量。同時，製造商正在追求模組化架構，以實現更小的尺寸、更高的生物相容性和針對多種適應症的快速配置。支付方和醫療系統要求提供可證明的臨床價值，因此，基於結果的證據和能夠減少加護病房住院時間的流程的重要性日益凸顯。因此，相關人員應將體外循環視為一個包含設備、耗材、培訓和售後支援的臨床服務包，而不僅僅是硬體。

展望未來，決策者必須認真考慮臨床療效、營運效率和生命週期成本，以及監管要求和供應鏈韌性，以使投資與組織優先事項保持一致，提高患者安全，並在醫療保健機構中維持先進的急性護理服務。

找出正在迅速改變體外循環系統開發和應用的技術進步、不斷發展的臨床實踐以及監管壓力。

體外循環領域正經歷著一場變革性的轉變，其驅動力包括泵浦技術、氧合器設計和系統整合方面的創新，以及臨床實踐模式的改變和監管機構對安全性和實際應用性能的日益重視。離心泵和磁浮泵因其溶血率低、流量控制更佳而日益普及，而氧合器的進步則主要集中在氣體交換效率和血栓形成傾向的降低。這些技術進步催生了新的系統結構，這些架構強調整合解決方案、可攜式平台和一次性組件策略，從而降低了交叉感染的風險。

隨著體外膜氧合（ECMO）適應症範圍的擴大，臨床通訊協定也不斷調整。 ECMO在重症呼吸衰竭和移植過渡治療中的應用，使得對可在加護病房和手術全期手術期快速部署的靈活的靜脈-動脈（VA）和靜脈-靜脈（VV）配置的需求日益成長。同時，醫院也更加重視縮短泵浦運轉運作和加快病患恢復，這使得設備的符合人體工學的設計、快速設定和直覺的監測介面變得尤為重要。

監管機構日益重視上市後監測、臨床資料提交以及關鍵零件的可追溯性。這種監管力度的加強促使製造商加強對品質系統和臨床證據產生的投入。此外，供應鏈中斷也提升了供應鏈韌性的策略重要性，促使製造商實現製造地多元化並加強與供應商的關係。這些因素共同推動著整個產業朝著更安全、更具適應性且更符合現代醫療路徑的方向發展。

了解近期關稅發展和貿易政策變化如何影響您所在行業的採購調整、成本再平衡和策略性製造應對措施。

2025年美國關稅調整、貿易政策審查和進口限制的累積效應，正為體外循環生態系中的製造商、經銷商和終端用戶帶來巨大的複雜性。進口醫療組件和成品醫療設備的關稅變化可能會改變到岸成本，促使企業重新評估籌資策略，並加速產能轉移和近岸外包。因此，擁有全球供應鏈的企業必須調整其跨國採購慣例，以適應新的關稅環境。

實際上，提高進口關稅可能會促使企業增加組裝的國產化率，從而帶動對本地製造業的資本投資或與美國本土契約製造的合作。雖然這些措施能夠提高供應可靠性並降低物流中斷的風險，但尋找替代供應商並確保設備和零件符合監管要求需要時間和資金。醫院和專科診所可能會在短期內遇到採購方面的摩擦，因為經銷商需要調整價格和庫存策略，但從中長期來看，供應商透明度的提高和前置作業時間的縮短將使它們受益。

政策主導的成本壓力將進一步激勵醫療設備製造商加快設計變革，旨在減少材料用量、提高模組化程度並實現在地化生產。總體而言，各組織應預見一段過渡期，其特點是成本重新平衡、供應商整合以及旨在增強長期韌性並適應新貿易環境的策略投資。

對產品、組件、技術、應用和最終用戶進行細分，以確定差異化的臨床需求和產業戰略路徑。

了解細分市場的細微差別對於解讀體外循環解決方案的產品開發路徑和臨床應用至關重要。根據產品類型，體外循環解決方案可分為心肺體外迴圈系統和體外膜氧合（ECMO）平台。心肺體外迴圈方案提供整合式和獨立式兩種形式，而ECMO則應用於心臟和呼吸系統：靜脈-動脈和靜脈-靜脈途徑。每類產品在工程設計、消毒和臨床培訓方面都有不同的要求，這些要求會影響醫療機構的採用模式。

組件層面的細分有助於明確技術供應鏈與臨床績效之間的權衡。熱交換器分為板式和管式兩種，其熱效率和預充能力各不相同。氧合器分為中空纖維式和膜式兩種，氣體交換特性也各有差異。泵的類型包括離心泵、磁浮和滾壓泵，這些類型在剪切應力和維護要求方面存在差異。管路材質的選擇範圍很廣，從PVC到矽膠，每種材質的生物相容性和操作特性都不同。這些組件的選擇會影響設備的壽命、處置策略以及臨床醫生的偏好。

技術細分進一步凸顯了離心泵、磁浮和滾壓泵在血液相容性、體積和整合複雜性方面各自獨特的優勢，從而指導研發投資方向。應用細分區分了心臟外科手術適應症（例如冠狀動脈繞道手術手術、瓣膜置換術和血管外科手術）和呼吸支持應用情境（例如急性呼吸窘迫症候群、移植過渡治療和 COVID 相關 ECMO 部署）。最後，終端使用者細分區分了進行心臟日間手術的門診手術中心、由綜合心臟中心和專科心臟中心組成的醫院，以及兒科中心和研究機構等專科診所。這些相互交織的細分維度共同構成了一個多維整體情況，指導產品定位、服​​務設計和市場推廣策略。

繪製美洲、歐洲、中東和非洲以及亞太地區在監管、臨床和採購模式方面的差異圖，以幫助制定區域商業化策略。

區域趨勢對體外循環領域的監管方式、採購行為和臨床實務模式有顯著影響。在美洲，集中化的報銷機制和對循證實踐的高度重視，促使製造商投資於臨床試驗和上市後監測，而醫療服務提供者則優先選擇那些能夠展現明顯營運優勢並改善患者預後的器械。該地區也傾向於與當地分銷商建立策略合作夥伴關係，以保持對先進急診中心的快速回應能力。

歐洲、中東和非洲地區的法規環境差異顯著，這要求製造商配備靈活的監管和市場進入小組，以應對各種不同的核准流程和報銷制度。臨床試驗中心的選擇通常需要在成本控制和採用先進技術之間取得平衡，從而推動了對可根據設施能力量身定做的模組化解決方案的需求。全部區域供應鏈的分散性促使製造商與區域物流專家和本地服務供應商建立合作關係，以確保耗材和維護的連續性。

在亞太地區，專科醫院的快速擴張以及對三級心臟和呼吸系統醫療項目投資的不斷成長，推動了對整合系統和組件供應的需求。現代化的監管和日益精細化的臨床專業化促進了先進泵浦和氧合器技術的應用，而多個國家的本土化生產則有助於降低價格。因此，相關人員應採取區域專業化策略，使產品組合、培訓計畫和服務模式與當地的臨床工作流程和採購慣例相契合。

透過系統整合、組件創新、臨床證據產生和供應鏈策略定位來評估競爭差異化優勢

體外循環系統市場的競爭格局是由成熟的設備產品組合和專業工程公司快速創新相結合而成，這種格局使得合作、收購和共同開發契約成為普遍現象。老牌製造商利用其品牌知名度和全球服務網路，持續為醫院和專科心臟中心提供產品；而新興參與企業則透過在泵浦技術、氧合器膜和一次性耗材設計方面進行重點改進，降低手術複雜性，從而挑戰現有企業的地位。

策略差異化日益聚焦於系統整合、臨床醫生培訓服務以及能夠提供即時性能數據並支援預防性維護的數位監測能力。投資於包含硬體、一次性耗材、軟體分析和教育項目的端到端解決方案的公司更有可能與醫療系統建立長期合作關係。同時，能夠提供小批量客製化和快速原型製作服務的零件供應商，對於尋求加速產品改進的原始設備製造商 (OEM) 而言，也是極具吸引力的合作夥伴。

供應鏈管理也是競爭的關鍵。擁有多元化製造地並與關鍵原料供應商保持深厚合作關係的公司，在應對供應中斷和關稅影響方面更具優勢。監管方面的專業知識和強大的臨床證據基礎能夠進一步提升競爭優勢，因為支付方和醫療服務提供方的採購團隊越來越重視那些能夠在產品生命週期內展現卓越績效和提供支持的供應商。

製造商和醫療保健系統提高體外循環系統採用率、增強供應鏈韌性和加強臨床證據的實用策略

體外循環領域的領導企業應採取一系列切實可行的措施，充分利用技術發展勢頭，同時降低營運和政策風險。應優先投資於血液相容性材料、低預充量設計以及可快速重新配置以支援靜脈-動脈和靜脈循環的模組化架構。這將使製造商能夠減輕臨床醫生的負擔，並滿足從心臟手術到呼吸支持等廣泛的臨床應用需求。

同時，企業應制定區域性生產和包裝策略，以降低關稅風險並縮短前置作業時間。與關鍵地區的委託製造建立牢固的合作關係或加強國內組裝能力，可以降低供應方面的脆弱性。這些措施，結合穩健的庫存計畫和關鍵零件的多元化供應來源，可以進一步保障業務營運免受中斷的影響。

透過有針對性的註冊研究和以降低溶血、提高氧合效率和減少器械相關併發症等結果為重點的實用臨床研究，加強臨床證據的產生。投資臨床醫生培訓計畫和基於模擬的課程，以加速安全應用並提升系統在市場上的受歡迎程度。最後，積極與監管機構和支付方溝通，協調產品標籤、報銷代碼和上市後監測的預期。這將有助於產品進入市場並支持長期的商業性永續性。

我們描述了一種多來源研究途徑，該方法結合了臨床醫生訪談、技術整合和數據三角測量，以提供有關醫療設備和臨床實踐動態的檢驗見解。

本執行摘要的調查方法融合了初步定性研究和全面的二次分析，以確保研究結果的可靠性和可重複性。一級資訊來源包括：心臟科和加護治療臨床醫生、醫院和專科診所的採購主管以及醫療設備製造商的高級工程領導。這些初步研究主要關注臨床工作流程、器械性能特徵、採購限制以及技術發展的預期趨勢。

二次研究涵蓋了監管申報文件、同行評審的臨床文獻、醫療設備技術規範和政策文件，以檢驗技術聲明並分析區域監管差異。研究採用數據三角測量技術來調和不同觀點，並識別不同臨床環境和地區之間的一致模式。此外，分析還納入了組件層面的技術比較，以揭示泵浦類型、氧合器結構和材料選擇的權衡取捨。

為確保研究質量，關鍵發現由獨立的臨床顧問進行交叉檢驗，並經過反覆審查以完善解讀。儘管存在一些限制因素，例如臨床實踐的快速發展和各地採購政策的潛在差異，但調查方法調查方法優先考慮透明度和可追溯性，有助於相關人員做出更有信心的決策。

我們概述了臨床需求、組件創新和政策促進因素的融合，以確定決定體外循環解決方案可擴展採用的因素。

總之，體外循環領域正邁入一個以系統整合、組件層級改進以及對實證醫學和供應穩定性日益成長的需求為特徵的階段。臨床上對可靠的靜脈-動脈和靜脈-靜脈配置的需求，以及對能夠最大限度減少血液損傷並簡化工作流程的泵和氧合器的偏好，持續影響著產品開發計劃。同時，政策變化和區域採購趨勢正迫使製造商和供應商重新評估其採購、生產和商業化策略。

將產品設計與臨床醫生需求相結合、投資於可驗證的臨床結果並建立靈活的供應鏈網路的相關人員，將獲得競爭優勢，同時提升患者安全並增強醫療機構應對複雜心臟和呼吸系統病例的能力。技術創新、法規遵循和營運可行性之間的相互作用，將決定哪些解決方案能夠有效地推廣到各種醫療機構，從門診心臟日間手術中心到三級醫療中心和兒科專科計畫。

總體而言，對模組化、證據生成和區域合作的戰略重點將使體外循環能力得以永續應用，從而滿足當代臨床和組織的需求。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧驅動的預測分析整合到體外循環管理中，以改善患者預後
  • 開發生物相容性塗層技術，以最大限度地減少體外循環過程中血栓的形成
  • 攜帶式體外膜氧合（ECMO）系統在院外嚴重患者照護的應用日益廣泛
  • 在心臟手術中採用封閉回路型自動灌注控制，以最佳化血流並減少併發症
  • 監管機構推動體外循環裝置標準化安全通訊協定和即時監測
  • 醫療設備製造商與學術研究人員合作，提高氧合器薄膜的耐久性和效率
  • 一種專門用於經皮介入心臟病學的微創體外循環支持系統的出現

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 體外循環系統市場（依產品類型分類）

  • 心肺體外迴圈系統
    • 整合系統
    • 獨立系統
  • 體外膜氧合器
    • 靜脈-動脈體外膜氧合（ECMO）
    • 靜脈-靜脈體外膜氧合（VV-ECMO）

第9章 體外循環系統市場（依組件分類）

  • 熱交換器
    • 板式熱交換器
    • 管式熱交換器
  • 氧合設備
    • 中空纖維氧合器
    • 膜式氧合器
  • 泵浦
    • 離心式幫浦
    • 磁浮泵浦
    • 滾筒幫浦
  • 管子
    • 聚氯乙烯管
    • 矽膠管

第10章 體外循環系統市場（依技術分類）

  • 離心式幫浦
  • 磁浮泵浦
  • 滾筒幫浦

第11章 體外循環系統市場（依應用領域分類）

  • 心臟手術
    • 冠狀動脈繞道手術手術
    • 閥門置換術
    • 血管外科
  • 呼吸輔助
    • 急性呼吸窘迫症候群
    • 移植橋樑
    • ECMO用於COVID-19患者

第12章 體外循環系統市場（依最終用戶分類）

  • 門診手術中心
    • 心臟日間手術
  • 醫院
    • 綜合醫院
    • 專業心臟中心
  • 專科診所
    • 兒科中心
    • 研究所

第13章 體外循環系統市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 體外循環系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國體外循環系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Medtronic plc
    • Terumo Corporation
    • Getinge AB
    • LivaNova PLC
    • Fresenius Medical Care AG & Co. KGaA
    • Baxter International Inc.
    • Edwards Lifesciences Corporation
    • Nipro Corporation
    • B. Braun Melsungen AG
    • Nikkiso Co., Ltd.
Product Code: MRR-CD5A9334D17A

The Extracorporeal Circulation System Market is projected to grow by USD 2.78 billion at a CAGR of 8.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.46 billion
Estimated Year [2025] USD 1.58 billion
Forecast Year [2032] USD 2.78 billion
CAGR (%) 8.36%

Framing the evolving clinical and technological imperatives that define extracorporeal circulation systems and influence procurement and adoption decisions

The contemporary field of extracorporeal circulation systems occupies a central role at the intersection of cardiac surgery and advanced respiratory support, powered by continuous technological refinement and evolving clinical protocols. Recent years have seen intensified focus on both cardiopulmonary bypass equipment and extracorporeal membrane oxygenation platforms as hospitals and specialty centers expand capabilities to manage complex cardiac operations and severe respiratory failure. This introductory overview frames the ecosystem by emphasizing clinical drivers, component-level innovation, and the policy context that shapes procurement and adoption decisions.

Clinicians increasingly demand systems that integrate safety features, ease of priming, and streamlined workflow to reduce operative time and improve patient throughput. Simultaneously, manufacturers pursue miniaturization, improved biocompatibility, and modular architectures that permit rapid configuration for diverse indications. Payers and health systems are pressing for demonstrable clinical value, which elevates the importance of outcomes-based evidence and procedures that shorten intensive care utilization. Therefore, stakeholders should view extracorporeal circulation not simply as hardware, but as a clinical service bundle comprising devices, disposables, training, and post-market support.

Moving forward, decision-makers must weigh clinical effectiveness, operational efficiency, and lifecycle cost while navigating regulatory expectations and supply chain resiliency. In doing so, they can align investments with institutional priorities to enhance patient safety and sustain high-acuity services across care settings.

Identifying the technological advances, clinical practice evolution, and regulatory pressures that are rapidly reshaping extracorporeal circulation system development and adoption

The landscape surrounding extracorporeal circulation is undergoing transformative shifts driven by innovation in pump technologies, oxygenator design, and systems integration, alongside changing clinical practice patterns and regulatory emphasis on safety and real-world performance. Centrifugal and magnetic levitation pumps have gained traction due to reduced hemolysis and improved flow control, while oxygenator advancements focus on gas exchange efficiency and thromboresistance. These engineering improvements enable newer system architectures that favor integrated solutions, portable platforms, and disposable component strategies that lower cross-contamination risk.

Clinical protocols are adapting as extracorporeal membrane oxygenation expands beyond traditional indications. Use in severe respiratory failure and as a bridge to transplant has created demand for flexible venoarterial and venovenous configurations that can be rapidly deployed in intensive care and perioperative environments. In parallel, hospitals emphasize shorter pump run times and faster recovery, which elevates the importance of device ergonomics, rapid setup, and intuitive monitoring interfaces.

Regulatory bodies increasingly require post-market surveillance, clinical data submission, and traceability for critical components. This regulatory tightening encourages manufacturers to invest in quality systems and clinical evidence generation. Additionally, supply chain resilience has ascended as a strategic priority following disruptions, prompting diversification of manufacturing footprints and stronger supplier relationships. Taken together, these forces are pushing the sector toward systems that are safer, more adaptable, and better aligned with contemporary care pathways.

Understanding how recent tariff developments and trade policy shifts contribute to sourcing realignment, cost rebalancing, and strategic manufacturing responses in the sector

The cumulative effect of tariff adjustments, trade policy revisions, and import restrictions implemented in the United States during 2025 introduces a material layer of complexity for manufacturers, distributors, and end users in the extracorporeal circulation ecosystem. Tariff changes on imported medical components and finished devices can alter landed costs, prompt re-evaluation of sourcing strategies, and accelerate relocation or nearshoring of production capabilities. Organizations with global supply chains must therefore reconcile cross-border procurement practices with the new duty environment.

In practice, increased import duties incentivize higher domestic content in assemblies, which can lead to capital investment in local manufacturing or partnerships with U.S.-based contract manufacturers. While such efforts can improve supply reliability and reduce exposure to logistic disruptions, they also require time and capital to qualify alternate suppliers and to ensure regulatory compliance for devices and components. Hospitals and specialty clinics might experience short-term procurement friction as distributors adjust pricing and inventory policies, but they may also benefit from improved vendor transparency and shorter lead times over the medium term.

Policy-driven cost pressures further motivate device makers to accelerate design changes that lower material intensity, enhance modularity, and enable regionalized production. In sum, organizations should anticipate a transition period marked by cost rebalancing, supplier consolidation, and strategic investments aimed at long-term resilience and alignment with the revised trade landscape.

Dissecting product, component, technology, application, and end-user segmentation to reveal differentiated clinical needs and industrial strategic pathways

A nuanced understanding of segmentation is essential to interpret product development pathways and clinical alignment across extracorporeal circulation offerings. Based on product type, the landscape encompasses cardiopulmonary bypass systems and extracorporeal membrane oxygenation platforms; cardiopulmonary bypass solutions present as integrated systems as well as standalone systems, while extracorporeal membrane oxygenation is deployed in venoarterial and venovenous modalities tailored to cardiac and respiratory indications respectively. Each product class imposes distinct engineering, sterilization, and clinical training requirements, which in turn influence adoption patterns across institutions.

Component-level segmentation clarifies technology supply chains and clinical performance trade-offs. Heat exchangers are available as plate and tubular designs with different thermal efficiencies and priming volumes; oxygenators are realized through hollow fiber and membrane constructions that vary in gas exchange properties; pumps include centrifugal, magnetic levitation, and roller formats that drive differences in shear stress and maintenance needs; tubing options span PVC and silicone, each with discrete biocompatibility and handling characteristics. These component choices shape device lifetime, disposables strategies, and clinician preferences.

Technology segmentation further highlights that centrifugal, magnetic levitation, and roller pump approaches each present unique benefits vis-a-vis hemocompatibility, footprint, and integration complexity, thereby guiding R&D investment. Application segmentation distinguishes cardiac surgery indications such as coronary artery bypass grafting, valve replacement, and vascular surgery from respiratory support use cases including acute respiratory distress syndrome, bridge to transplant, and COVID-related ECMO deployment. Finally, end-user segmentation differentiates ambulatory surgery centers with cardiac day surgery workflows, hospitals comprising general and specialized cardiac centers, and specialty clinics such as pediatric centers and research institutes. Together, these intersecting segmentation vectors create a multi-dimensional picture that informs product positioning, service design, and go-to-market strategies.

Mapping divergent regulatory, clinical, and procurement patterns across the Americas, Europe Middle East and Africa, and Asia Pacific to inform regional commercialization strategies

Regional dynamics exert a powerful influence on regulatory approach, procurement behavior, and clinical practice patterns across the extracorporeal circulation domain. In the Americas, centralized reimbursement frameworks and a strong emphasis on evidence-based adoption encourage manufacturers to invest in clinical trials and post-market studies while healthcare providers prioritize devices that demonstrate clear operational and patient outcome benefits. This region also favors strategic partnerships with local distributors to maintain rapid response capabilities for high-acuity centers.

In Europe, Middle East & Africa, regulatory environments vary considerably, prompting manufacturers to maintain flexible regulatory and market access teams that can navigate divergent approval pathways and reimbursement regimes. Clinical preferences often reflect a balance between cost containment and the adoption of advanced technology, which spurs modular solutions that can be tailored by facility capability. Supply chain fragmentation across the region incentivizes partnerships with regional logistics specialists and local service providers to ensure continuity of consumables and maintenance.

Across Asia-Pacific, rapid capacity expansion of specialty hospitals and increasing investment in tertiary cardiac and respiratory programs are driving demand for both integrated systems and component supplies. Regulatory modernization and rising clinical expertise support adoption of advanced pump and oxygenator technologies, while domestic manufacturing in several countries contributes to competitive pricing dynamics. Stakeholders should therefore adopt region-specific strategies that align product configurations, training programs, and service models with local clinical workflows and procurement practices.

Evaluating competitive differentiation driven by systems integration, component innovation, clinical evidence generation, and supply chain strategic positioning

Competitive dynamics within extracorporeal circulation systems combine legacy device portfolios with rapid innovation from specialized engineering firms, creating a landscape in which partnerships, acquisitions, and co-development agreements are common. Established manufacturers continue to leverage brand recognition and global service networks to supply hospitals and specialized cardiac centers, while emerging entrants challenge incumbents through focused improvements in pump technology, oxygenator membranes, and disposable consumable design that reduce procedural complexity.

Strategic differentiation increasingly centers on systems integration, clinician training services, and digital monitoring capabilities that provide real-time performance data and enable preventive maintenance. Companies that invest in end-to-end solutions-comprising hardware, disposables, software-enabled analytics, and education programs-tend to secure longer-term relationships with health systems. At the same time, component suppliers that offer low-volume customization and rapid prototyping are attractive partners for original equipment manufacturers seeking to accelerate product enhancements.

Supply chain control is another axis of competition; firms that maintain diversified manufacturing footprints and deep supplier relationships for critical materials are better positioned to manage disruptions and tariff impacts. Regulatory expertise and a robust clinical evidence base further amplify competitive advantage, as payers and provider procurement teams increasingly favor suppliers who can demonstrate outcomes and support across the product lifecycle.

Actionable strategies for manufacturers and health systems to accelerate adoption, build supply resilience, and strengthen clinical evidence supporting extracorporeal systems

Leaders in the extracorporeal circulation space should adopt a set of pragmatic actions to capitalize on technological momentum while mitigating operational and policy risks. Prioritize investments in hemocompatible materials, low-prime-volume designs, and modular architectures that enable rapid reconfiguration for venoarterial or venovenous support. By doing so, manufacturers can reduce clinician burden and broaden the addressable clinical use cases across cardiac surgery and respiratory support.

Concurrently, develop regional manufacturing and packaging strategies to mitigate tariff exposure and improve lead times. Establishing validated partnerships with contract manufacturers in key geographies or enhancing domestic assembly capabilities will reduce supply fragility. Complementing these moves with robust inventory planning and multi-sourcing for critical components will further insulate operations from disruption.

Strengthen clinical evidence generation through targeted registries and pragmatic clinical studies focused on outcomes such as hemolysis rates, oxygenation efficiency, and device-related complication reduction. Invest in clinician training programs and simulation-based curricula to accelerate safe adoption and to build preference for your systems. Finally, engage proactively with regulators and payers to align product labeling, reimbursement coding, and post-market surveillance expectations, which will smooth market access and support longer-term commercial sustainability.

Explaining the multi-source research approach that combines clinician interviews, technical synthesis, and data triangulation to deliver validated insights into device and clinical practice dynamics

The research methodology underpinning this executive summary integrates a blend of primary qualitative inquiry and comprehensive secondary source synthesis to ensure robust, reproducible insights. Primary inputs included structured interviews with practicing cardiac and critical care clinicians, procurement executives from hospitals and specialty clinics, and senior engineering leaders within device firms. These conversations focused on clinical workflows, device performance attributes, procurement constraints, and anticipated technology trajectories.

Secondary research encompassed regulatory filings, peer-reviewed clinical literature, device technical specifications, and policy documents to validate technical claims and to contextualize regional regulatory differences. Data triangulation techniques were applied to reconcile divergent viewpoints and to identify consistent patterns across clinical settings and geographies. The analysis also incorporated component-level technical comparison to illuminate trade-offs between pump types, oxygenator constructions, and material choices.

Quality assurance included cross-validation of key findings with independent clinical advisors and iterative review cycles to refine interpretations. Limitations pertain to rapidly evolving clinical practice and potential variability in local procurement policies; nonetheless, the methodological approach prioritizes transparency and traceability to support confident decision-making by stakeholders.

Summarizing the convergence of clinical demand, component innovation, and policy drivers that will determine the scalable adoption of extracorporeal circulation solutions

In conclusion, the extracorporeal circulation domain is transitioning to a phase characterized by integrated systems, component-level refinement, and heightened expectations for evidence and supply resilience. Clinical demand for reliable venoarterial and venovenous configurations, coupled with preferences for pumps and oxygenators that minimize blood trauma and streamline workflows, continues to shape product roadmaps. At the same time, policy changes and regional procurement dynamics compel manufacturers and providers to reassess sourcing, manufacturing, and commercialization strategies.

Stakeholders who align product design with clinician needs, invest in demonstrable clinical outcomes, and build flexible supply networks will secure competitive advantage while enhancing patient safety and institutional readiness for complex cardiac and respiratory cases. The interplay between technological innovation, regulatory diligence, and operational execution will determine which solutions scale effectively across diverse care settings, from ambulatory cardiac day surgery facilities to tertiary referral centers and specialized pediatric programs.

Overall, a strategic focus on modularity, evidence generation, and regional alignment will enable durable adoption of extracorporeal circulation capabilities that meet contemporary clinical and organizational imperatives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven predictive analytics in extracorporeal circulation management to enhance patient outcomes
  • 5.2. Development of biocompatible coating technologies to minimize thrombus formation during extracorporeal procedures
  • 5.3. Rising adoption of portable extracorporeal membrane oxygenation systems for out-of-hospital critical care support
  • 5.4. Shift towards closed-loop automated perfusion control in cardiac surgery to optimize blood flow and reduce complications
  • 5.5. Regulatory impetus for standardized safety protocols and real-time monitoring in extracorporeal circulation devices
  • 5.6. Collaboration between medical device manufacturers and academic researchers to improve oxygenator membrane durability and efficiency
  • 5.7. Emergence of minimally invasive extracorporeal circulatory support systems tailored for percutaneous cardiovascular interventions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Extracorporeal Circulation System Market, by Product Type

  • 8.1. Cardiopulmonary Bypass System
    • 8.1.1. Integrated Systems
    • 8.1.2. Standalone Systems
  • 8.2. Extracorporeal Membrane Oxygenation
    • 8.2.1. Venoarterial Ecmo
    • 8.2.2. Venovenous Ecmo

9. Extracorporeal Circulation System Market, by Component

  • 9.1. Heat Exchanger
    • 9.1.1. Plate Heat Exchanger
    • 9.1.2. Tubular Heat Exchanger
  • 9.2. Oxygenator
    • 9.2.1. Hollow Fiber Oxygenator
    • 9.2.2. Membrane Oxygenator
  • 9.3. Pump
    • 9.3.1. Centrifugal Pump
    • 9.3.2. Magnetic Levitation Pump
    • 9.3.3. Roller Pump
  • 9.4. Tubing
    • 9.4.1. Pvc Tubing
    • 9.4.2. Silicone Tubing

10. Extracorporeal Circulation System Market, by Technology

  • 10.1. Centrifugal Pump
  • 10.2. Magnetic Levitation Pump
  • 10.3. Roller Pump

11. Extracorporeal Circulation System Market, by Application

  • 11.1. Cardiac Surgery
    • 11.1.1. Coronary Artery Bypass Grafting
    • 11.1.2. Valve Replacement
    • 11.1.3. Vascular Surgery
  • 11.2. Respiratory Support
    • 11.2.1. Acute Respiratory Distress Syndrome
    • 11.2.2. Bridge To Transplant
    • 11.2.3. Covid Ecmo

12. Extracorporeal Circulation System Market, by End User

  • 12.1. Ambulatory Surgery Centers
    • 12.1.1. Cardiac Day Surgery
  • 12.2. Hospitals
    • 12.2.1. General Hospitals
    • 12.2.2. Specialized Cardiac Centers
  • 12.3. Specialty Clinics
    • 12.3.1. Pediatric Centers
    • 12.3.2. Research Institutes

13. Extracorporeal Circulation System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Extracorporeal Circulation System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal Circulation System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Medtronic plc
    • 16.3.2. Terumo Corporation
    • 16.3.3. Getinge AB
    • 16.3.4. LivaNova PLC
    • 16.3.5. Fresenius Medical Care AG & Co. KGaA
    • 16.3.6. Baxter International Inc.
    • 16.3.7. Edwards Lifesciences Corporation
    • 16.3.8. Nipro Corporation
    • 16.3.9. B. Braun Melsungen AG
    • 16.3.10. Nikkiso Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. EXTRACORPOREAL CIRCULATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. EXTRACORPOREAL CIRCULATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EXTRACORPOREAL CIRCULATION SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC DAY SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC DAY SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC DAY SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC DAY SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC DAY SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC DAY SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MI